These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1024 related articles for article (PubMed ID: 29363886)
1. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy. Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886 [TBL] [Abstract][Full Text] [Related]
2. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells. Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486 [TBL] [Abstract][Full Text] [Related]
3. Honokiol induces autophagic cell death in malignant glioma through reactive oxygen species-mediated regulation of the p53/PI3K/Akt/mTOR signaling pathway. Lin CJ; Chen TL; Tseng YY; Wu GJ; Hsieh MH; Lin YW; Chen RM Toxicol Appl Pharmacol; 2016 Aug; 304():59-69. PubMed ID: 27236003 [TBL] [Abstract][Full Text] [Related]
4. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase. Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328 [TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells. Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776 [TBL] [Abstract][Full Text] [Related]
6. Urolithin A, induces apoptosis and autophagy crosstalk in Oral Squamous Cell Carcinoma via mTOR /AKT/ERK1/2 pathway. Remadevi V; Jaikumar VS; Vini R; Krishnendhu B; Azeez JM; Sundaram S; Sreeja S Phytomedicine; 2024 Jul; 130():155721. PubMed ID: 38788395 [TBL] [Abstract][Full Text] [Related]
7. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways. Jiang JH; Pi J; Jin H; Cai JY J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997 [TBL] [Abstract][Full Text] [Related]
8. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679 [TBL] [Abstract][Full Text] [Related]
9. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling. Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083 [TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line. Qiu Y; Li C; Wang Q; Zeng X; Ji P Cancer Med; 2018 Feb; 7(2):397-407. PubMed ID: 29316373 [TBL] [Abstract][Full Text] [Related]
11. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo. He W; Lai R; Lin Q; Huang Y; Wang L J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794 [TBL] [Abstract][Full Text] [Related]
12. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo. Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403 [TBL] [Abstract][Full Text] [Related]
13. Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway. Li Z; Dong H; Li M; Wu Y; Liu Y; Zhao Y; Chen X; Ma M Mol Med Rep; 2018 Feb; 17(2):2719-2723. PubMed ID: 29207060 [TBL] [Abstract][Full Text] [Related]
14. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. Lee B; Kim CH; Moon SK FEBS Lett; 2006 Oct; 580(22):5177-84. PubMed ID: 16962592 [TBL] [Abstract][Full Text] [Related]
15. Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy. Ji S; Tang S; Li K; Li Z; Liang W; Qiao X; Wang Q; Yu S; Ye M Toxicol Appl Pharmacol; 2017 Jul; 326():25-33. PubMed ID: 28416456 [TBL] [Abstract][Full Text] [Related]
16. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells. Fang L; Wang H; Zhou L; Yu D Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis. Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H PLoS One; 2013; 8(2):e56381. PubMed ID: 23418564 [TBL] [Abstract][Full Text] [Related]
18. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Hahm ER; Singh SV Mol Cancer Ther; 2007 Oct; 6(10):2686-95. PubMed ID: 17938262 [TBL] [Abstract][Full Text] [Related]
19. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer. Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164 [TBL] [Abstract][Full Text] [Related]
20. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells. Kaushik G; Ramalingam S; Subramaniam D; Rangarajan P; Protti P; Rammamoorthy P; Anant S; Mammen JM Am J Surg; 2012 Dec; 204(6):868-73. PubMed ID: 23231930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]